Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age and is characterized by menstrual abnormalities, clinical or biochemical hyperandrogenism, multiple abnormal cysts and enlarge ovaries. Women affected by PCOS often suffer of insulin resistance and of a compensatory hyperinsulinemia which put them at risk of developing several metabolic disorders. Inositol is a six-carbon polyol which has been characterized as an insulin sensitizer: it exists as nine different isomers and among them myo-inositol and D-chiroinositol are the most represented and studied in physiology and physiopathology. In particular, myo-inositol (MI) and D-chiro inositol (DCI) glycans administration has been reported to exert beneficial effects at metabolic, hormonal and ovarian levels.
The aim of this randomized study is to evaluate the metabolic and ovaric effects of a six-month supplementation of myo-inositol and D-chiro-inositol on young women with PCOS and hyperinsulemia.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Folic acid | Active Comparator |
| |
| Inofolic Combi | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Myo-inositol + D-chiro-inositol + Folic acid | Dietary Supplement | Myo-inositol (550 mg) + D-chiro-inositol (13.8 mg) + Folic acid (200 mcg); 2 x die |
|
| Measure | Description | Time Frame |
|---|---|---|
| Menstrual cycle restoration | At 6 months | |
| Score hirsutism (Ferriman-Gallwey classification) | At 6 months | |
| Serum progesterone | At 6 months | |
| Testosterone level test | At 6 months | |
| Oral glucose tolerance test (OGTT) | Evaluation of glycemia and insulinemia levels | At 6 months |
| Homeostasis Model Assessment (HOMA-index) | At 6 months | |
| Sex hormone binding globulin (SHBG) test | At 6 months | |
| Androstenediol level test | At 6 months | |
| Androstenedione level test | At 6 months | |
| Free Androgen Index (FAI) level test | At 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Body Mass Index (BMI) | At 6 months | |
| Change from baseline in diastolic blood pressure levels | At 6 months | |
| Change from baseline in systolic blood pressure levels |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Pisa - Department of Endocrinology | Pisa | Italy |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 10566641 | Background | Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab. 1999 Nov;84(11):4006-11. doi: 10.1210/jcem.84.11.6148. | |
| 9165656 | Background |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008659 | Metabolic Diseases |
| ID | Term |
|---|---|
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D007294 | Inositol |
| D005492 | Folic Acid |
| ID | Term |
|---|---|
| D013402 | Sugar Alcohols |
| D000438 | Alcohols |
| D009930 | Organic Chemicals |
| D002241 | Carbohydrates |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Folic acid | Dietary Supplement | Folic acid (200 mcg); 2 x die |
|
| At 6 months |
| Number of patients with abnormal ovarian size and morphology | Ovarian ultrasound scan for the assessment of size and morphology | At 6 months |
| Luteinizing Hormone (LH) level test | Analysis of LH levels should be performed between the 7th and the 10th day of the cycle | At 6 months |
| Follicle Stimulating Hormone (FSH) level test | Analysis of FSH levels should be performed between the 7th and the 10th day of the cycle | At 6 months |
| Estradiol (E2) level test | Analysis of E2 levels should be performed between the 7th and the 10th day of the cycle | At 6 months |
| Nestler JE. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications. Semin Reprod Endocrinol. 1997 May;15(2):111-22. doi: 10.1055/s-2007-1016294. |
| 18375940 | Background | Baillargeon JP, Nestler JE, Ostlund RE, Apridonidze T, Diamanti-Kandarakis E. Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism. Hum Reprod. 2008 Jun;23(6):1439-46. doi: 10.1093/humrep/den097. Epub 2008 Mar 29. |
| 10219066 | Background | Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med. 1999 Apr 29;340(17):1314-20. doi: 10.1056/NEJM199904293401703. |
| 12042283 | Background | Chiu TT, Rogers MS, Law EL, Briton-Jones CM, Cheung LP, Haines CJ. Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Hum Reprod. 2002 Jun;17(6):1591-6. doi: 10.1093/humrep/17.6.1591. |
| 10523012 | Background | Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999 Oct;84(10):3666-72. doi: 10.1210/jcem.84.10.6079. |
| 14752302 | Background | Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv. 2004 Feb;59(2):141-54. doi: 10.1097/01.OGX.0000109523.25076.E2. |
| D011622 |
| Pterins |
| D011621 | Pteridines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |